Falsifications and unauthorised imitation products Criminals falsify the labels of commercially available pens or supply active substances that are still being researched as illegally manufactured preparations in some cases with potentially life-threatening consequences
36 Figure 21: Subgroup analyses for PIONEER 1 to 5, 7 to 8: A1C (%) by body weight (kg) vvvv v vvvvvvvvvvvvvv vvv v vvvv vvvvvvvv vvvv vvvvv v vvvvvvvv vvvvvvvvvvv vvvv v vvvvvvvvvvvv vvvv v vvvvvvvvvvvv vvvv v vvvvvvvvvvvv vvvv vvvv vvv vvvvvvvv vvvvvvvvvvv vvvvvvv vvvvvvvv vvvvvvvvv vvv vvvvvvvvv vvvvvv vvvvvvvvv vvvvvv vvvvv vvvv vvvvvvvvvvvvvv vv vvvvvvvvv vvvvvvvvvvvvvvv vv vvvvvvvvv vvv vvvvvvvvvv vv vvvvvv vvvvvvvvvvv vvvvvvv vvvvvv vvvv vvvvvvv vv v vvvvvvv vvvvvvv vvvvv vvvvv vvvvvvvv vvvvvvvvvvv vvvvvvv vvv vvvvvvv vv vvvvvvvvvv vvvvvvvvv vvv vvvvvvvvv vvvvvvv Figure 21 was redacted at the sponsors request
Received: 11 Jun 2025 | Revised: 29 Jul 2025 | Accepted: 31 Jul 2025 | Published: 27 Jan 2026 1
If symptoms are intolerable, your prescriber may recommend slowing the dose-escalation schedule, which is a recognised and effective strategy for improving tolerability across the GLP-1 drug class
Those with certain variants may tolerate faster titration, while others benefit from extended intervals
I value their transparency and their commitment to doing what's in the best interest of the patients